GOV.F Insulet Corporation

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
134.00 EUR
Close of Nov 13, 2026
112.45 304.00
Market cap
EUR 9.30B
P/E
25.4x
P/B
6.63x
ROE
27.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is GOV.F undervalued?

Graham number
Price134.00
Graham value48.94
Premium173.8%

GOV.F trades 173.8% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Insulet Corporation fundamental analysis

No fundamental analysis for Insulet Corporation yet.

Insulet Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin m…

Full company profile